Nov 6, 2024, 08:27 AM by

Oxford Nanopore announced a landmark strategic partnership that brings together Genomics England, UK Biobank, and NHS England to enable genomics-based translational research and accelerate the development and adoption of Oxford Nanopore’s ground-breaking genomics technology in the NHS.

Nov 4, 2024, 08:55 AM by

Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, and Domainex, a multi-award winning provider of integrated, pre-clinical drug discovery services, today announced that Domainex is the first contract research organization (CRO) to have installed the eProtein Discovery system and offer protein production services using the technology.

Nov 4, 2024, 01:00 AM by User Not Found

Bio-IT World | The traditional LDL and HDL cholesterol tests may soon be obsolete as new research suggests they provide an incomplete view of heart health compared to other lipid molecules circulating in the blood. This shift stems from a recent study led by Dr. Cristina Legido-Quigley, a systems medicine expert at King’s College London and Steno Diabetes Centre, which analyzed lipids in children with obesity.

Nov 1, 2024, 08:05 AM by

Endor Labs, the leader in open source software security, has once again been selected to the prestigious Fortune Cyber 60 list, the second consecutive year it has received this recognition.

Nov 1, 2024, 08:05 AM by

PathAI, a leader in digital and AI-powered pathology solutions, and VIZIA Diagnostics, a GI- specialized pathology laboratory based in Alpharetta, Georgia, have announced that VIZIA has adopted PathAI’s AISightⓇ1 Image Management System (IMS) and AI technology to advance the precision and operational efficiency of its pathology services.

Nov 1, 2024, 08:05 AM by

Nov 1, 2024, 08:05 AM by

Nov 1, 2024, 08:05 AM by

Oct 31, 2024, 01:00 AM by User Not Found

Bio-IT World | Harvard scientists have succeeded in using artificial intelligence (AI) to identify promising drug candidates for diseases for which there are no examples of successful treatment. The graph foundation model, known as TxGNN, opens untold opportunities to repurpose drugs for the thousands of diseases afflicting small populations and exacting a huge toll in terms of both economics and human suffering.

Oct 30, 2024, 07:21 AM by

Phreesia announced that it has achieved Oracle Validated Integration with Oracle Health Electronic Health Record (EHR) Expertise for its integration of the Phreesia platform.

Oct 30, 2024, 07:21 AM by

VALANX Biotech (VALANX) and Fina Biosolutions LLC (FinaBio) today announced the signing of a joint IP and licensing agreement. The companies will launch ClickCRM™, a ready-to-conjugate version of CRM197, an antigenic carrier protein used for making conjugate vaccines. The new product enables the rapid, high-efficiency conjugation of carrier proteins to polysaccharide antigens for the generation of conjugate vaccines.

Oct 30, 2024, 07:21 AM by

Sapio Sciences today announced it has strengthened its long-term relationship with Amazon Web Services, Inc. (AWS) through the integration of AWS Bedrock with the Sapio Platform. This integration makes advanced generative AI models readily accessible to scientists and researchers within the same secure AWS environment that already powers Sapio’s Laboratory Information Management System (LIMS) and Electronic Lab Notebook (ELN).

Oct 30, 2024, 07:21 AM by

Today, Quris-AI announced the acquisition of Nortis. Nortis' high-quality microphysiology systems (MPS) database and ability to accurately mimic human biology provided a unique value proposition, perfectly aligning with Quris-AI's mission to improve drug safety prediction. Nortis’s Kidney-on-Chip models, which set new standards for in-vitro drug testing and personalized medicine, will be combined with Quris-AI’s advanced machine learning models and patented patient-on-chip system that can predict a real human body’s reaction to drugs and eliminate potentially harmful drug candidates earlier in the drug development process.

Oct 30, 2024, 01:00 AM by User Not Found

Bio-IT World | Modifi Biosciences has been acquired by Merck; Sapio Sciences announces the addition of new immunogenicity bioanalysis features to its industry-leading lab informatics platform; and more.

Oct 29, 2024, 08:24 AM by

Coronado Research announced today that Professor Jennifer Visser-Rogers has been appointed as Chief Scientific Officer.

Oct 29, 2024, 08:24 AM by

Takara Bio Europe has announced the expansion of its Gothenburg facility, with the addition of a custom manufacturing lab. This new facility now offers a comprehensive array of customised molecular biology products, including PCR and qPCR enzymes, servicing the molecular biology needs of academic researchers, diagnostic labs, and biotech companies across EMEA, producing up to 600,000 reactions per week. With these expanded capabilities, customers can expect faster deliveries, personalised service, and real-time access to technical expertise, ensuring projects move forward efficiently while supporting sustainability goals through reduced carbon emissions.

Oct 29, 2024, 01:00 AM by User Not Found

Bio-IT World | Terray Therapeutics will enhance their integrated AI platform, tNova, which identifies and optimizes novel small molecule solutions to the most complex problems; Basecamp Research, in collaboration with the laboratory of Dr. David R. Liu at the Broad Institute of MIT and Harvard, plans to advance their data collection and strengthen their AI capabilities; and more.

Oct 28, 2024, 08:04 AM by

RBQM innovator CluePoints has today announced that Richard Young has been appointed as its new Chief Strategy Officer. With 30 years of experience in clinical data management, Richard is an expert in his field.

Oct 25, 2024, 08:52 AM by

Sapio Sciences today announced the addition of new Electronic Batch Record (EBR) functionality to Sapio GMP (Good Manufacturing Practice) LIMS. Designed for laboratories that must comply with GMP, 21 CFR 11, and EU Annex 11 standards, the Sapio GMP LIMS offers unparalleled flexibility to meet compliance standards in biotechnology, pharmaceuticals, clinical research and diagnostics, food and beverage, chemicals, and environmental testing.

Oct 25, 2024, 01:00 AM by User Not Found

Bio-IT World | Applied artificial intelligence (AI) is already transforming drug discovery research and development, accelerating the journey from lab to lifesaving therapies, and both the reality and the hype are very well known. Less obvious—almost 90% of the iceberg—is the critical role played by data.